Results 211 to 220 of about 11,269,395 (356)

Development and Characterization of Novel ELISAs for the Specific Quantification of the Factor H-Related Proteins 2, 3, 4, and 5. [PDF]

J Innate Immun
van Rossum M, Veuskens BRJ, Brouwer MC, van Mierlo G, Lucientes-Continente L, Goicoechea de Jorge E, Uzonyi B, Matola AT, Józsi M, Müller G, Meter-Arkema AM, Poppelaars F, Pauly D, Pouw RB, Toonen EJM.   +14 more
europepmc   +1 more source

Epidermal growth factor: exposure and dynamics of the aromatic side chains as investigated by photo‐CIDNP and variable temperature ¹H‐NMR [PDF]

, 1983
Antonio De Marco, Enea Menegatti, Mario Guarneri   +2 more
openalex   +1 more source

Comparing self‐reported race and genetic ancestry for identifying potential differentially methylated sites in endometrial cancer: insights from African ancestry proportions using machine learning models

Molecular Oncology, EarlyView.
Integrating ancestry, differential methylation analysis, and machine learning, we identified robust epigenetic signature genes (ESGs) and Core‐ESGs in Black and White women with endometrial cancer. Core‐ESGs (namely APOBEC1 and PLEKHG5) methylation levels were significantly associated with survival, with tumors from high African ancestry (THA) showing ...
Huma Asif, J. Julie Kim
wiley   +1 more source

D/H and 18O/16O fractionation factors in evaporation of water at 60 and 80.DEG.C.

, 1978
Osamu Matsubaya, Hitoshi Sakai
openalex   +2 more sources

Pituitary Binding of³H-Labeled Sertoli Cell Factorin Vitro: A Potential Radioreceptor Assay for Inhibin* [PDF]

, 1984
L. Seethalakshmi, Anna Steinberger, E. Steinberger   +2 more
openalex   +1 more source

The atypical KRASQ22K mutation directs TGF‐β response towards partial epithelial‐to‐mesenchymal transition in patient‐derived colorectal cancer tumoroids

Molecular Oncology, EarlyView.
TGF‐β has a complex role in cancer, exhibiting both tumor‐suppressive and tumor‐promoting properties. Using a series of differentiated tumoroids, derived from different stages and mutational background of colorectal cancer patients, we replicate this duality of TGF‐β in vitro. Notably, the atypical but highly aggressive KRASQ22K mutation rendered early‐
Theresia Mair, Philip König, Milena Mijović, Jessica Kalla, Anil Baskan, Loan Tran, Kristina Draganić, Pedro Morata Saldaña, Carlos Uziel Pérez Malla, Janette Pfneissl, Andreas Tiefenbacher, Julijan Kabiljo, Velina S. Atanasova, Lisa Wozelka‐Oltjan, Leonhard Müllauer, Michael Bergmann, Raheleh Sheibani‐Tezerji, Gerda Egger   +17 more
wiley   +1 more source

Factor H: a novel modulator in sickle cell disease

Haematologica, 2019
Wassim El Nemer, Bérengère Koehl
doaj   +1 more source

Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G. [PDF]

Front Immunol
Tschongov T, Konwar S, Kleindienst J, Dabrowska-Schlepp P, Busch A, Schaaf A, Schell C, Rogg M, Häffner K.   +8 more
europepmc   +1 more source

Factors influencing reactivity of thermal H(T) atoms with solids. I. Physical effects [PDF]

, 1985
Richard E. Ehrenkaufer, Wylie C. Hembree, Alfred P. Wolf   +2 more
openalex   +1 more source

A large‐scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression‐free survival

Molecular Oncology, EarlyView.
There is an unmet need in metastatic breast cancer patients to monitor therapy response in real time. In this study, we show how a noninvasive and affordable strategy based on sequencing of plasma samples with longitudinal tracking of tumour fraction paired with a statistical model provides valuable information on treatment response in advance of the ...
Emma J. Beddowes, Mario Ortega Duran, Solon Karapanagiotis, Alistair Martin, Meiling Gao, Riccardo Masina, Ramona Woitek, James Tanner, Fleur Tippin, Justine Kane, Jonathan Lay, Anja Brouwer, Stephen‐John Sammut, Suet‐Feung Chin, Davina Gale, Dana W. Y. Tsui, Sarah‐Jane Dawson, Nitzan Rosenfeld, Maurizio Callari, Oscar M. Rueda, Carlos Caldas   +20 more
wiley   +1 more source